Neuroinflammation

Neuroinflammation refers to the inflammatory response within the central nervous system (CNS) that involves the activation of glial cells (microglia and astrocytes), the release of cytokines and chemokines, and changes in neural tissue. It is a complex biological process that can be either protective or pathological, depending on its duration, intensity, and the underlying causes. While acute neuroinflammation is a natural and protective response to injury, infection, or disease, chronic neuroinflammation can lead to neuronal damage and is implicated in numerous neurological and psychiatric disorders.

Key Players in Neuroinflammation:

A. Microglia

  • Microglia are the resident immune cells of the CNS and play a critical role in neuroinflammation.
  • In response to injury, infection, or pathological changes, microglia undergo activation, where they change shape, proliferate, and release inflammatory mediators such as cytokines (e.g., IL-1β, TNF-α) and reactive oxygen species (ROS).
  • Microglia can adopt different activation states:
    • M1 phenotype: Pro-inflammatory, releasing cytokines that exacerbate neuroinflammation and neuronal injury.
    • M2 phenotype: Anti-inflammatory, promoting repair and tissue remodeling, although persistent activation can shift microglia back to a harmful M1 state.

B. Astrocytes

  • Astrocytes also play a significant role in neuroinflammation by releasing inflammatory cytokines and chemokines.
  • They regulate the blood-brain barrier (BBB) and help manage the ionic environment around neurons, contributing to the neuroinflammatory response.
  • Reactive astrocytes are associated with tissue damage in neurodegenerative diseases, releasing both neurotoxic and neuroprotective factors depending on the context.

C. Peripheral Immune Cells

  • In certain conditions, peripheral immune cells such as T cells, B cells, and monocytes infiltrate the CNS, contributing to the inflammatory response.
  • Cytokines produced by these immune cells can enter the brain through a compromised BBB and further stimulate neuroinflammation.
  • The presence of peripheral immune cells in the CNS is particularly notable in autoimmune diseases like multiple sclerosis (MS).

D. Blood-Brain Barrier (BBB)

  • The BBB is a selective barrier that typically prevents harmful substances and immune cells from entering the brain.
  • During neuroinflammation, the integrity of the BBB is compromised, allowing immune cells and inflammatory mediators to infiltrate the brain.
  • BBB breakdown is a hallmark of many neuroinflammatory diseases and contributes to the progression of damage.

    Related Conference of Neuroinflammation

    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    35th Euro Congress on Neurologists and Psychiatrists

    Tokyo, Japan
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    January 25-26, 2027

    22nd Annual Conference on Dementia and Alzheimers Disease

    Singapore City, Singapore
    February 11-12, 2027

    9th World Depression Congress

    Tokyo, Japan
    March 18-19, 2027

    10th World Congress on Epilepsy and Brain Disorders

    Paris, France
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 22-23, 2027

    9th World Conference on Neuroscience

    Rome, Italy
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland
    April 15-15, 2027

    8th Global Summit on Brain Disorders and Therapeutics

    Amsterdam, Netherlands
    June 14-15, 2027

    6th International Conference on Alzheimer and Dementia

    Barcelona, Spain
    June 24-25, 2027

    11th Annual Neurologists and Neurosurgeons Meet

    Dublin, Ireland
    June 24-25, 2027

    19th International Congress on Neurology Surgery

    Dublin, Ireland

    Neuroinflammation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in